| Literature DB >> 31935371 |
Jermaine Goveia1, Katerina Rohlenova1, Federico Taverna1, Lucas Treps1, Lena-Christin Conradi1, Andreas Pircher1, Vincent Geldhof1, Laura P M H de Rooij1, Joanna Kalucka1, Liliana Sokol1, Melissa García-Caballero1, Yingfeng Zheng2, Junbin Qian3, Laure-Anne Teuwen1, Shawez Khan1, Bram Boeckx3, Els Wauters4, Herbert Decaluwé5, Paul De Leyn5, Johan Vansteenkiste4, Birgit Weynand6, Xavier Sagaert6, Erik Verbeken6, Albert Wolthuis7, Baki Topal7, Wouter Everaerts8, Hanibal Bohnenberger9, Alexander Emmert10, Dena Panovska11, Frederik De Smet11, Frank J T Staal12, Rene J Mclaughlin12, Francis Impens13, Vincenzo Lagani14, Stefan Vinckier1, Massimiliano Mazzone15, Luc Schoonjans1, Mieke Dewerchin1, Guy Eelen1, Tobias K Karakach1, Huanming Yang16, Jian Wang16, Lars Bolund17, Lin Lin17, Bernard Thienpont18, Xuri Li19, Diether Lambrechts3, Yonglun Luo20, Peter Carmeliet21.
Abstract
Heterogeneity of lung tumor endothelial cell (TEC) phenotypes across patients, species (human/mouse), and models (in vivo/in vitro) remains poorly inventoried at the single-cell level. We single-cell RNA (scRNA)-sequenced 56,771 endothelial cells from human/mouse (peri)-tumoral lung and cultured human lung TECs, and detected 17 known and 16 previously unrecognized phenotypes, including TECs putatively regulating immune surveillance. We resolved the canonical tip TECs into a known migratory tip and a putative basement-membrane remodeling breach phenotype. Tip TEC signatures correlated with patient survival, and tip/breach TECs were most sensitive to vascular endothelial growth factor blockade. Only tip TECs were congruent across species/models and shared conserved markers. Integrated analysis of the scRNA-sequenced data with orthogonal multi-omics and meta-analysis data across different human tumors, validated by functional analysis, identified collagen modification as a candidate angiogenic pathway.Entities:
Keywords: angiogenesis; anti-angiogenic therapy; cancer; endothelial cells; endothelial heterogeneity; multi-omics; single-cell RNA sequencing
Year: 2020 PMID: 31935371 DOI: 10.1016/j.ccell.2019.12.001
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743